Eiko Lifesciences Ltd — Insider Trading, 01-01-1970: Insider Trading / SAST

Lenus Finvest Private Limited, a Promoter Group entity of Eiko Lifesciences, acquired 1,75,000 equity shares and 1,50,000 warrants via a preferential allotment. This raised Lenus Finvest's total holding to 25,40,472 equity shares, representing 17.71% of the non-diluted share capital. After converting all warrants, their total stake would be 26,90,472 shares, or 15.56% of the fully diluted share capital. Eiko Lifesciences' equity share capital increased from ₹13.72 Cr to ₹14.35 Cr post-allotment, reflecting the expanded capital base. This transaction signifies an increased stake by the promoter group in the company.